Skip to main content
    A

    Azitra Inc (AZTR)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • AMEX

    $0.60
    -0.01 (-1.38%)

    Market Cap: $3.69M

    Last updated: Nov 17, 2026 at 11:03 AM ET

    Azitra Inc (AZTR) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Azitra are Dermata Therapeutics (DRMA), Traws Pharma (TRAW) and XTL Biopharmaceuticals Ltd ADR (XTLB). By market cap, Azitra ranks 9th of the 13 companies on this page; Theriva Biologics (TOVX) is the largest at $6.61M.

    Peer Comparison

    AZTR's revenue growth of -100.0% is below the peer median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Azitra (AZTR)$3.69MN/AN/A0.0%N/A-100.0%0.00%
    Dermata Therapeutics Inc (DRMA)$3.06MN/A41.3x0.0%N/A0.0%0.00%
    Traws Pharma Inc (TRAW)$3.86MN/AN/A0.0%N/A-100.0%0.00%
    XTL Biopharmaceuticals Ltd ADR (XTLB)$3.93MN/A4.0x0.0%N/A0.0%0.00%
    Bioatla Inc (BCAB)$2.89MN/AN/A0.0%N/A31.6%0.00%
    PharmaCyte Biotech Inc (PMCB)$3.77MN/AN/A0.0%N/A0.0%0.00%
    Ernexa Therapeutics Inc. (ERNA)$2.84MN/AN/A0.0%N/A-94.1%0.00%
    Theriva Biologics Inc. (TOVX)$6.61MN/A21.5x0.0%-52.3%0.0%0.00%
    Aprea Therapeutics Inc (APRE)$5.91MN/AN/A0.0%N/A-98.4%0.00%
    BioRestorative Therapies Inc (BRTX)$2.06MN/A70.3x0.0%-289.9%-7.3%0.00%
    GRI Bio Inc. (GRI)$3.72MN/AN/A0.0%N/A0.0%0.00%
    Skye Bioscience, Inc. Common Stock (SKYE)$4.83MN/AN/A0.0%-3685.3%0.0%0.00%
    Creative Medical Technology Holdings Inc (CELZ)$4.01MN/AN/A0.0%N/A0.0%0.00%
    Peer median$3.82MN/A31.4x0.0%-289.9%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Azitra, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Dermata Therapeutics Inc (DRMA)
    Dermata Therapeutics Inc. is a clinical-stage biotechnology company focused on developing innovative therapies for dermatological conditions...
    DRMA competitors
    Traws Pharma Inc (TRAW)
    Traws Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer in the United States.
    TRAW competitors
    XTL Biopharmaceuticals Ltd ADR (XTLB)
    XTL Biopharmaceuticals Ltd., a biopharmaceutical company, is engaged in the acquisition and development of pharmaceutical products for the treatment...
    Bioatla Inc (BCAB)
    BioAtla, Inc., a biopharmaceutical company, develops specific and selective antibody-based therapies for the treatment of various cancers.
    BCAB competitors
    PharmaCyte Biotech Inc (PMCB)
    PharmaCyte Biotech, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cell therapies for cancer and diabetes in the United...
    PMCB competitors
    Ernexa Therapeutics Inc. (ERNA)
    Brooklyn ImmunoTherapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to developing therapies to treat cancer patients.
    ERNA competitors
    Theriva Biologics Inc. (TOVX)
    Theriva Biologics Inc., a clinical-stage company, develops therapies to treat diseases in areas of high unmet need.
    TOVX competitors
    Aprea Therapeutics Inc (APRE)
    Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and markets cancer therapies that reactivate the mutant p53 tumor suppressor...
    APRE competitors
    BioRestorative Therapies Inc (BRTX)
    BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue...
    BRTX competitors
    GRI Bio Inc. (GRI)
    GRI Bio Inc. is an innovative biotechnology company focused on leveraging microbiome technology to develop cutting-edge therapeutics in immunology and oncology.
    GRI competitors
    Skye Bioscience, Inc. Common Stock (SKYE)
    Skye Bioscience, Inc., a clinical stage biopharmaceutical company, discovers, develops...
    SKYE competitors
    Creative Medical Technology Holdings Inc (CELZ)
    Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics...
    CELZ competitors

    Frequently Asked Questions About AZTR

    Who are Azitra's main competitors?

    The companies most similar to Azitra include Dermata Therapeutics (DRMA), Traws Pharma (TRAW), XTL Biopharmaceuticals Ltd ADR (XTLB), Bioatla (BCAB) and PharmaCyte Biotech (PMCB), listed from the closest match.

    Who is Azitra's biggest competitor?

    Theriva Biologics (TOVX) is the largest of the similar companies at $6.61M; Dermata Therapeutics (DRMA) is the closest match by business profile, size, sector and industry.

    How does AZTR stock compare with its competitors?

    AZTR's net margin is 0.0% against a peer median of 0.0%.

    Which of Azitra's competitors pays a higher dividend?

    Azitra pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Azitra bigger than its competitors?

    No. Azitra is 9th by market cap among the 13 companies on this page; the largest is Theriva Biologics (TOVX) at $6.61M.